Diabetes, hemoglobin A(1c), cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population

American Journal of Kidney Diseases

Volumn 36, Issue 2, 2000, Pages 272-281

  Chi yuan, Hsu ^a,b,c,d   Bates, David W ^a,b,c,d   Kuperman, Gilad J ^a,b,c,d   Curhan, Gary C ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Partners Information Systems   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diabetes mellitus; Epidemiology; Hypercholesterolemia; Moderate chronic renal insufficiency

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR;

EID: 0034256025     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.8971     Document Type: Article

References (55)

1. Wei GL, Coresh J, Jones CA, McQuillan G, Brancati FL, Klag MJ: High blood pressure and the burden of renal insufficiency in the United States: NHANES III (1989- 1994). J Am Soc Nephrol 9:162A, 1998 (abstr)
2. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Hypertension 13:S80-S93, 1989 (suppl I)
3. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300:297-300, 1990
4. Friedman PJ: Serum creatinine: An independent predictor of survival after stroke. J Intern Med 229:175-179, 1991
5. Matts JP, Karnegis JN, Campos CT, Fitch LL, Johnson JW, Buchwald H: Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. J Fam Pract 36:497-503, 1993
6. Diamond JR, Karnovsky MJ: A putative role of hypercholesterolemia in progressive glomerular injury. Ann Rev Med 43:83-92, 1992
7. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP: Hyperlipidemia and progressive renal disease. Kidney Int 39:S41-S48, 1991 (suppl 31)
8. Mulec H, Johnson S-A, Bjorck S: Relation between serum cholesterol and diabetic nephropathy. Lancet 335: 1537-1538, 1990
9. Krolewski AS, Warram JH, Christlieb AR: Hypercholesterolemia - A determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 45:S125- S131, 1994 (suppl 45)
10. Ravid M, Savin H, Jutrin I, Bental T, Lang R, Lishner M: Long-term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II. Kidney Int 45 :S161- S164, 1994 (suppl 45)
11. Mulec H, Johnsen SA, Wiklund O, Bjorck S: Cholesterol: A renal risk factor in diabetic nephropathy? Am J Kidney Dis 22:196-201, 1993
12. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R: Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 158:998-1004, 1998
13. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
14. Feest TG, Round A, Hamad S: Incidence of severe renal failure in adults: Results of a community based study. BMJ 306:481-483, 1993
15. Coresh J, Wu K, Folsom AR, Brancati FL, Nieto FJ, Klag MJ, Whelton PK: Fibrinogen, factor VIII and von Willebrand factor predict a decline in renal function: ARIC 3-year follow-up data. J Am Soc Nephrol 9:606A, 1998 (abstr)
16. Cox DR: Regression models and life-tables. J Royal Stat Soc B 34:187-220, 1972
17. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, NY, Wiley, 1989
18. Zhang J, Yau KF: What's the relative risk? JAMA 1280:1690-1691, 1998
19. Hou SH, Bushinshy DA, Wish JB, Cohen JJ, Harrington JT: Hospital-acquired renal insufficiency: A prospective study. Am J Med 74:243-248, 1983
20. Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J: Preoperative renal risk stratification. Circulation 95:878-884, 1997
21. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: Blood pressure and end-stage renal disease in men. N Engl J Med 334:13-18, 1996
22. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ: Risk of end-stage renal disease in diabetes mellitus. JAMA 278:2069-2074, 1997
23. Buckalew VM, Berg RL, Wang S-R, Porush JG, Rauch S, Schulman G: Prevalence of hypertension in 1,795 subjects with chronic renal disease: The modification of diet in renal disease study baseline cohort. Am J Kidney Dis 28:811-821, 1996
24. Levin A, Singer J, Thompson CR, Ross H, Lewis M: Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 27:347-354, 1996
25. Sechi LA, Zingaro L, De Carli S, Sechi G, Catena C, Falleti E, Dell'anna E, Bartoli E: Increased serum lipoprotein(a) levels in patients with early renal failure. Ann Intern Med 129:457-461, 1998
26. Jungers P, Massy ZA, Khoa TN, Fumeron C, Labrunie M, Lacour B, Descamps-Latscha B, Man NK: Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 12:2597-2602, 1997
27. Frassetto LA, Morris RC, Sebastian A: Effect of age on blood acid-base composition in adult humans: Role of age-related renal function decline. Am J Physiol 271:F1114- F1122, 1996
28. Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB: Hyperparathyroidism and 1,25- Dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab 67:876-881, 1988
29. Malluche HH, Ritz E, Lange HP, Kutschera J, Hodgson M, Seiffert U, Schoeppe W: Bone histology in incipient and advanced renal failure. Kidney Int 9:355-362, 1976
30. Smith JW, Seidl LG, Cluff LE: Studies on the epidemiology of adverse drug reactions. Ann Intern Med 65:629- 640, 1966
31. Ritz E: Nephropathy in type 2 diabetes. J Intern Med 245:111-126, 1999
32. Perneger TV, Brancati FL, Whelton PK, Klag MK: End-stage renal disease attributable to diabetes mellitus. Ann Intern Med 121:912-918, 1994
33. US Renal Data System: 1998 Annual Data Report. Am J Kidney Dis 32:S38-S49, 1998 (suppl 1)
34. Nathan DM: The pathophysiology of diabetic complications: How much does the glucose hypothesis explain? Ann Intern Med 124:86-89, 1996
35. Weiss MF, Rodby RA, Justice AC, Hricik DE: Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Kidney Int 54:193-202, 1998
36. Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawano K, Tsukada Y: Increased serum levels of advanced glycation end-products and diabetic complications. Diabetes Res Clin Pract 41:131-137, 1998
37. Marcantoni C, Ortalda V, Lupo A, Maschio G: Progression of renal failure in diabetic nephropathy. Nephrol Dial Transplant 13:S16-S19, 1998 (suppl 8)
38. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977- 986, 1993
39. Viberti GC, Mogensen CE, Passa P, Bilous R, Mangili R: St Vincent Declaration, 1994: Guidelines for the prevention of diabetic renal failure, in Mogensen CE (ed): The Kidney and Hypertension in Diabetes Mellitus. Boston, MA, Kluwer Academic, 1994, pp 515-527
40. Ravid M, Savin H, Lang R, Jutrin I, Shoshana L, Lishner M: Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. Arch Intern Med 152:1225-1229, 1992
41. Nielsen S, Schmitz A, Rehling M, Mogensen CE: Systolic blood pressure relates to the rate of decline of glomerular filtration rate in type II diabetes. Diabetes Care 16:1427-1432, 1993
42. Gall M-A, Nielsen FS, Smidt UM, Parving H-H: The cause of kidney disease in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 36:1071-1078, 1993
43. Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, Ujihara U, Takahashi C, Omori Y: Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 40:405-411, 1997
44. Hasslacher C, Bostedt-Kiesel A, Kempe HP, Wahl P: Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1051-1056, 1993
45. Washio M, Okuda S, Ikeda M, Kirakata H, Nanishi F, Onoyama K, Yoshimura T, Fujishima M: Hypercholesterolemia and the progression of the renal dysfunction in chronic renal failure patients. J Epidemiol 6:172-177, 1996
46. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
47. Vannini P, Ciavarella A, Flammini M, Bargossi AM, Forlani G, Borgnino LC, Orsoni G: Lipid abnormalities in insulin-dependent diabetic patients with albuminuria. Diabetes Care 7:151-154, 1984
48. Jensen T, Stender S, Deckert T: Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31:142-145, 1988
49. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered membrane permeability to macromolecules? Kidney Int 38:384-394, 1990
50. Moorhead JF, Chan MK, El-Nahas M, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet 2:1309-1311, 1982
51. Coresh J, Toto RD, Kirk KA, Whelton PK, Massry S, Jones C, Agodoa L, Van Lente F: Creatinine clearance as a measure of GFR in screenees for the African American study of kidney disease and hypertension pilot study. Am J Kidney Dis 32:32-42, 1998
52. Culleton BF, Larson MG, Evans JC, Wilson PWF, Barrett BJ, Parfrey PS, Levy D: Prevalence and correlates of elevated serum creatinine levels. Arch Intern Med 159:1785- 1790, 1999
53. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE: Predictors of the progression of renal disease in the modification of diet in renal disease study. Kidney Int 51:1908-1919, 1999
54. Manttari M, Tiula E, Alikoski T, Manninen V: Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 26:670-675, 1995
55. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthrone VM: Disparities in incidence of diabetic end- stage renal disease according to race and type of diabetes. N Engl J Med 321:1974-1979, 1989